- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (133)
- Timeline of Article Publication (7)
- Authors Evaluation (4)
- Article Quality Tracking (1)
- Reference Citation Analysis (4)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2360)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2023 (publication date) through May 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang HC, Huang X, Chen J, Li Y, Cong Y, Qu BL, Feng SQ, Liu F. Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world. World J Gastroenterol 2023; 29(41): 5641-5656 [PMID: 38077159 DOI: 10.3748/wjg.v29.i41.5641] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i41/5641.htm |
| Number | Citing Articles |
| 1 |
Kazumasa Yamamoto, Shun Yamamoto, Ken Kato. Pembrolizumab for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus: a drug safety evaluation. Expert Opinion on Drug Safety 2024; : 1 doi: 10.1080/14740338.2024.2348554
|